Aadi Bioscience Announces Closing of $100 Million PIPE Financing
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 04 2025
0mins
Source: PRnewswire
Private Placement Announcement: Aadi Bioscience, Inc. has successfully closed a private placement led by Ally Bridge Group, raising approximately $100 million through the sale of 21,592,000 shares of common stock and pre-funded warrants.
Use of Proceeds: The funds will be utilized for upfront payments under a license agreement with WuXi Biologics and for general corporate purposes, supporting operations into 2028, including clinical data readouts for its ADC portfolio.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
